BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4254217)

  • 1. Enhancement of coronary reactive hyperemia in unanesthetized pigs by an adenosine-potentiator (Lidoflazine).
    Jageneau AH; Schaper WK; Van Gerven W
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 265(1):16-23. PubMed ID: 4254217
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological effects on coronary reactive hyperemia in conscious dogs.
    Juhran W; Voss EM; Dietmann K; Schaumann W
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 269(1):32-47. PubMed ID: 4252441
    [No Abstract]   [Full Text] [Related]  

  • 3. Potentiation of adenosine activity by low oral doses of lidoflazine.
    Jageneau AH; Schaper WK
    Nature; 1969 Jan; 221(5176):184-5. PubMed ID: 5782714
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement of coronary vasodilating action of ATP and adenosine by lidoflazine.
    Afonso S; O'Brien GS; Crumpton CW
    Circ Res; 1968 Jan; 22(1):43-8. PubMed ID: 5635208
    [No Abstract]   [Full Text] [Related]  

  • 5. Myocardial reactive hyperemia responses in the dog after aminophylline and lidoflazine.
    Bittar N; Pauly TJ
    Am J Physiol; 1971 Mar; 220(3):812-5. PubMed ID: 4322835
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronary vasodilator responses to hypoxia and induced tachycardia before and after lidoflazine.
    Afonso S
    Am J Physiol; 1969 Feb; 216(2):297-300. PubMed ID: 5766980
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of lidoflazine in atrial muscle.
    Ilhan M; Kayaalp SO
    Arzneimittelforschung; 1973 May; 23(5):640-1. PubMed ID: 4740202
    [No Abstract]   [Full Text] [Related]  

  • 8. The cardiovascular pharmacology of lidoflazine.
    Schaper W; Jageneau A; Xhonneux R
    Brux Med; 1970 Sep; 50(9):635-8. PubMed ID: 5510364
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of coronary vasodilator action of nicotinamide adenine dinucleotide by lidoflazine.
    Afonso S; O'Brien GS; Berndt TB; Ansfield TJ; Rowe GG
    J Pharmacol Exp Ther; 1971 Dec; 179(3):573-9. PubMed ID: 4333026
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhancement of the muscular effects of adenosine by lidoflazine and dipyridamole in isolated atria.
    Küçükhüseyin C; Kayaalp SO
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):243-50. PubMed ID: 4851866
    [No Abstract]   [Full Text] [Related]  

  • 11. Differences among dipyridamole, carbochromen and lidoflazine in responses of the coronary and the renal arteries.
    Sano N; Sato S; Hashimoto K
    Jpn J Pharmacol; 1972 Dec; 22(6):857-65. PubMed ID: 4541491
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancement of coronary vasodilator action of adenosine triphosphate by dipyridamole.
    Afonso S; O'Brien GS
    Circ Res; 1967 Apr; 20(4):403-8. PubMed ID: 6025404
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of lidoflazine on coronary circulation and myocardial metabolism in anesthetized and unanesthetized dogs.
    Takenaka T; Tachikawa S
    Arzneimittelforschung; 1970 Mar; 20(3):351-4. PubMed ID: 5467508
    [No Abstract]   [Full Text] [Related]  

  • 14. The disappearance of adenosine in blood. Effect of lidoflazine and other drugs.
    Van Belle H
    Eur J Pharmacol; 1970 Jul; 11(2):241-8. PubMed ID: 5447806
    [No Abstract]   [Full Text] [Related]  

  • 15. Stimulation of the coronary collateral circulation by lidoflazine (R 7904).
    Schaper WK; Xhonneux R; Jageneau AH
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1965 Nov; 252(1):1-8. PubMed ID: 4222721
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the mechanism of action of coronary dilators].
    Kraupp O
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):144-55. PubMed ID: 5804227
    [No Abstract]   [Full Text] [Related]  

  • 17. Potentiation of the coronary vasodilator effect of norepinephrine by 2,6-bis (diethanolamino)-4,8-dipiperidino-pyrimido (5,4-d) pyrimidine (dipyridamole).
    Hashimoto K; Sano N
    Tohoku J Exp Med; 1968 Oct; 96(2):207-8. PubMed ID: 5708523
    [No Abstract]   [Full Text] [Related]  

  • 18. Potentiation of reactive hyperemia in the coronary and femoral circulation by the selective use of 2,6-bis(diethanolamino)-4,8-dipiperidino-pyrimodo[5,4-d]pyrimidine.
    Miura M; Tominaga S; Hashimoto K
    Arzneimittelforschung; 1967 Aug; 17(8):976-9. PubMed ID: 5632072
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of lidoflazine and flunarizine on cerebral reactive hyperemia.
    Phillis JW; DeLong RE; Towner JK
    Eur J Pharmacol; 1985 Jun; 112(3):323-9. PubMed ID: 4018140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of lidoflazine and other coronary vasodilators after oral administration in the trained non-anesthetized dog.
    Jageneau A; Schaper W
    Arzneimittelforschung; 1967 May; 17(5):582-7. PubMed ID: 4969448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.